Mutation Panel News Today

The advanced tools and technologies enable improved flexibility and productivity for diagnostics development

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics. During the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory ...

CHICAGO--(BUSINESS WIRE)--Jul 25, 2022--

Thermo Fisher Scientific, a world leader in serving science, has announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed with a customizable menu of real-PCR genotyping assays to accurately identify known SARS-COV-2 variants in just over an hour.

- Panel is Designed for the Qualitative Detection of Four SARS-CoV-2 Genomic Mutations, Three of Which are Classified by the CDC as Substitutions of Therapeutic Concern - - Panel is Designed to... | October 25, 2021

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced signing

Adoption of innovative testing strategies like mutation panels will enable government and healthcare bodies to not only manage the pandemic but also empower laboratories to abet such outbreaks in the future

Thermo Fisher Scientific , the world leader in serving science, has announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains. First launched in March 2021, the research panel features a customizable menu of verified real-time PCR assays for identification of SARS-CoV-2 mutations.

Published: Apr 07, 2021    - Program Powered by Applied DNA’s Mutation-targeted qPCR Assays and NGS Platform - - Program Data Potentially Relevant to COVID-19 Vaccine and Therapeutics Developers, Precision Medicine -   STONY BROOK & NEW HYDE PARK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc.. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and Northwell Health (Northwell) today announced their entry into a ...

Product News: Thermo Fisher Scientific launches panel to monitor for COVID-19 mutations Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19 12 Mar 2021 Thermo Fisher Scientific, a world leader in serving science, has announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations. These assays enable surveillance of variants that are causing C...